| |
 |
|
Class Information
Number: 514/649
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Nitrogen containing other than solely as a nitrogen in an inorganic ion of an addition salt, a nitro or a nitroso doai > Benzene ring containing > Amino nitrogen attached to aryl ring or aryl ring system by an acyclic carbon or acyclic chain
Description: Subject matter wherein an amino nitrogen is indirectly bonded to an aryl ring system through a single carbon or through an acyclic chain.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7071194 |
Method for improving respiratory function and inhibiting muscular degeneration |
Jul. 4, 2006 |
| 7067555 |
Sertraline oral concentrate |
Jun. 27, 2006 |
| 7053072 |
Methods for the administration of amifostine and related compounds |
May. 30, 2006 |
| 7053120 |
Use of carboxy compounds such as 2(4-acetoxyphenyl)2-chloro-N-methyl-ethylammonium chloride as anti-inflammatory agents |
May. 30, 2006 |
| 7053122 |
Therapeutic use of aryl amino acid derivatives |
May. 30, 2006 |
| 7049329 |
Amines that inhibit a mammalian anandamide transporter, and methods of use thereof |
May. 23, 2006 |
| 7034059 |
Methods of using norfluoxetine |
Apr. 25, 2006 |
| 7034036 |
Inhibitors of ABC drug transporters at the blood-brain barrier |
Apr. 25, 2006 |
| 7030164 |
Crystalline polymorph of venlafaxine hydrochloride and methods for the preparation thereof |
Apr. 18, 2006 |
| 7022678 |
Pregabalin lactose conjugates |
Apr. 4, 2006 |
| 7011844 |
Formulations for the administration of fluoxetine |
Mar. 14, 2006 |
| 7012071 |
Compounds for the treatment of metabolic disorders |
Mar. 14, 2006 |
| 7012099 |
Use of substituted 4-amino-1-phenylbutan-2-ol compounds as medicaments |
Mar. 14, 2006 |
| 6984389 |
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality |
Jan. 10, 2006 |
| 6960577 |
Combination therapy for treatment of refractory depression |
Nov. 1, 2005 |
| 6960574 |
Antagonists of RF-amide neuropeptides |
Nov. 1, 2005 |
| 6953797 |
Use of phenylheteroalkylamine derivatives |
Oct. 11, 2005 |
| 6949534 |
Cell adhesion inhibitors |
Sep. 27, 2005 |
| 6949530 |
Nitric oxide-releasing amidine diazeniumdiolates, compositions and uses thereof and method of making same |
Sep. 27, 2005 |
| 6946491 |
Compounds for the treatment of metabolic disorders |
Sep. 20, 2005 |
| 6939856 |
Method for preparing dexchlor tannate |
Sep. 6, 2005 |
| 6932985 |
Azide method and composition for controlling deleterious organisms |
Aug. 23, 2005 |
| 6927223 |
Use of serotonin agents for adjunct therapy in the treatment of cancer |
Aug. 9, 2005 |
| 6924313 |
Substituted tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
Aug. 2, 2005 |
| 6919317 |
Pharmaceutical composition comprising squalene epoxidase inhibitor and macrolide immunomodulator |
Jul. 19, 2005 |
| 6911479 |
Methods of treating and preventing pain, anxiety, and incontinence using derivatives of (-)-venlafaxine |
Jun. 28, 2005 |
| 6911217 |
Controlled release bead, a method of producing the same and multiple unit formulation comprising it |
Jun. 28, 2005 |
| 6906104 |
Aminediols for the treatment of Alzheimer's disease |
Jun. 14, 2005 |
| 6900203 |
Optically active fluorinated vasoconstrictors, methods for making them, and anesthetic formulations comprising them |
May. 31, 2005 |
| 6900243 |
Phenylheteroalkylamine derivatives |
May. 31, 2005 |
| 6881744 |
Carbinoxamine tannate |
Apr. 19, 2005 |
| 6878721 |
Beta2-adrenoceptor agonists |
Apr. 12, 2005 |
| 6852341 |
Azide method and composition for controlling deleterious organisms and for stimulating beneficial organisms |
Feb. 8, 2005 |
| 6846492 |
Use of phenylethylamine derivatives for the antimicrobial treatment of surfaces |
Jan. 25, 2005 |
| 6846837 |
Topical administration of basic antifungal compositions to treat fungal infections of the nails |
Jan. 25, 2005 |
| 6841575 |
Use of 1-phenyl-3-dimethylaminopropane compounds for treatment of urinary incontinence |
Jan. 11, 2005 |
| 6809090 |
Derivatives of N-(iminomethy)amines, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
Oct. 26, 2004 |
| 6797707 |
Antagonists of RF-amide neuropeptides |
Sep. 28, 2004 |
| 6770636 |
Phenyl-and phenylalkyl-substituted ethanolamines and ethylenediamines |
Aug. 3, 2004 |
| 6765023 |
Use of substituted N, N-disubstituted reverse aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
Jul. 20, 2004 |
| 6765022 |
Cyclohexylamine derivatives as subtype selective nmda receptor antagonists |
Jul. 20, 2004 |
| 6730706 |
Treatments using venlafaxine |
May. 4, 2004 |
| 6730329 |
Zinc containing compositions for anti-viral use |
May. 4, 2004 |
| 6727283 |
Sertraline oral concentrate |
Apr. 27, 2004 |
| 6723753 |
Substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
Apr. 20, 2004 |
| 6723749 |
Fatty acid synthase inhibitors |
Apr. 20, 2004 |
| 6723752 |
(R)-chiral halogenated substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
Apr. 20, 2004 |
| 6683114 |
Treatment of psoriasis |
Jan. 27, 2004 |
| 6683113 |
(R)-chiral halogenated substituted N,N-Bis-benzyl aminioalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
Jan. 27, 2004 |
| 6683099 |
Substituted N,N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
Jan. 27, 2004 |
|
|
|
